Provided by Tiger Trade Technology Pte. Ltd.

Disc Medicine

62.06
+1.292.12%
Post-market: 62.060.00000.00%19:30 EDT
Volume:691.14K
Turnover:43.14M
Market Cap:2.38B
PE:-9.46
High:63.50
Open:60.67
Low:60.03
Close:60.77
52wk High:99.50
52wk Low:40.00
Shares:38.39M
Float Shares:32.95M
Volume Ratio:0.87
T/O Rate:2.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.5619
EPS(LYR):-6.0116
ROE:-39.08%
ROA:-23.96%
PB:3.70
PE(LYR):-10.32

Loading ...

Morgan Stanley Raises Price Target on Disc Medicine to $80 From $75, Keeps Overweight Rating

MT Newswires Live
·
May 14

Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress

GlobeNewswire
·
May 12

Disc Medicine joins H.C. Wainwright BioConnect investor conference fireside chat

Reuters
·
May 11

Disc Medicine to Participate in Upcoming Investor Conferences

GlobeNewswire
·
May 11

Disc Medicine (IRON) Gets a Buy from LifeSci Capital

TIPRANKS
·
May 10

Disc Medicine (IRON) Receives a Buy from H.C. Wainwright

TIPRANKS
·
May 07

Disc Medicine Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 05

Disc Medicine reports Q1 EPS ($1.65), consensus ($1.73)

TIPRANKS
·
May 05

Disc Medicine posts smaller-than-expected Q1 net loss

Reuters
·
May 05

Disc Medicine Q1 EPS $(1.65) Beats $(1.73) Estimate

Benzinga Earnings
·
May 05

Earnings Flash (IRON) Disc Medicine Posts Q1 Net Loss $1.65 a Share, vs. FactSet Est of $1.65 Loss

MT Newswires Live
·
May 05

Disc Medicine Q1 Net Income USD -63.504 Million VS. Ibes Estimate USD -67.1 Million

THOMSON REUTERS
·
May 05

Press Release: Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
May 05

How Investors Are Reacting To Disc Medicine (IRON) After FDA Letter Triggers Shareholder Investigation

Simply Wall St.
·
May 05

Press Release: LABRADOR IRON ORE ROYALTY CORPORATION - RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2026

Dow Jones
·
May 05

Press Release: CHAMPION IRON REPORTS ITS FY2026 FOURTH QUARTER PRODUCTION AND SALES

Dow Jones
·
Apr 30

Disc Medicine announces annual shareholder meeting via webcast

Reuters
·
Apr 29

Mabwell Q1 net loss narrows to RMB 241.94 million; revenue triples to RMB 127.6 million

Reuters
·
Apr 28

Will Insider 10b5-1 Sales and New ASCO Data Shift Disc Medicine's (IRON) Narrative?

Simply Wall St.
·
Apr 24

Disc Medicine Completes Key Phase 1b Study of DISC-0974 in CKD Anemia: What Investors Should Watch

TIPRANKS
·
Apr 24